$1,890.00

AsPC-1 SMAD/TGFbeta Reporter (Luc) stable cell line

Catalog number
CL-1471
Description
AsPC-1 SMAD/TGFbeta Reporter (Luc) cells are derived from the human pancreas adenocarcinoma AsPC-1 cell line by stably integration of a SMAD/TGFbeta firefly luciferase reporter construct. AsPC-1 cell line has been widely used in cancer research and drug development. AsPC-1 SMAD/TGFbeta Reporter (Luc) cells stably express firefly luciferase under the control of the SMAD/TGFbeta response elements, can be used for monitoring the activity of TGFβ/SMAD signaling pathway.

Product Details

Package Size 2 x 10^6 cells
Parental cell line AsPC-1 cells
Transgenic gene Firefly luciferase
Mammalian selection Puromycin
Biosafety level 2
Storage Liquid nitrogen
Availability 3-4 weeks
Shipping condition dry ice
Copyright © 2024, FenicsBIO. All rights reserved.